Group 6 Copy 422
-1
    Please wait...

    About This Project

    An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan parasite Trypanosoma cruzi that results in Chagas’ disease, a neglected tropical disease (NTD). Principally spread by the kissing bug (cover image), there exists an urgent need for development of new therapeutics to replace the outdated clinically used drugs, benznidazole and nifurtimox. Our research focuses on the discovery of novel antichagasic compounds for improved medicine.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Thermal and Fluid Dynamical Effects on the Efficiency of Hyperpolarized Xenon Production

    The American Lung Association estimates that 32 million Americans are affected by lung diseases, many of...

    Can a Dietary Intervention Reduce Mercury Toxicity Among Native Communities in Peru?

    A state of emergency has been declared in Madre de Dios, Peru due to high levels of mercury (Hg) exposure...

    S-glutathionylation reactions in mitochondrial function and disease

    This project was an invited review that is currently under minor revision at Frontiers Cellular and Developmental...

    Backer Badge Funded

    A medicine project funded by 19 people